Metacrine, Inc.
FARNESOID X RECEPTOR AGONISTS FOR THE TREATMENT OF DISEASE

Last updated:

Abstract:

Described herein are combination therapies with famesoid X receptor (FXR) agonists, and methods of using such pharmaceutical compositions in the treatment of conditions, diseases, or disorders associated with famesoid X receptor activity.

Status:
Application
Type:

Utility

Filling date:

17 Sep 2019

Issue date:

17 Feb 2022